https://orcid.org/0000-0002-0755-7560
References
- Margot H, Boursier G, Duflos C, et al. Immunopathological manifestations in Kabuki syndrome: a registry study of 177 individuals. Genet Med. 2020;22(1):181–188. doi: 10.1038/s41436-019-0623-x.
- Saha BK. Idiopathic pulmonary hemosiderosis: a state of the art review. Respir Med. 2021;176:106234. doi: 10.1016/j.rmed.2020.106234.
- Gürbüz F, Özalp Yüreğir Ö, Ceylaner S, et al. Coexistence of Kabuki Syndrome and autoimmune thyroiditis. Jcrpe. 2016;8(1):105–106. doi: 10.4274/jcrpe.2686.
- Oto J, Mano A, Nakataki E, et al. An adult patient with Kabuki syndrome presenting with Henoch-Schönlein purpura complicated with pulmonary hemorrhage. J Anesth. 2008;22(4):460–463. doi: 10.1007/s00540-008-0656-9.
- Das S, Cherian S, Hamarneh W, et al. Diffuse alveolar hemorrhage secondary to idiopathic thrombocytopenic purpura; an extremely rare presentation. Chest. 2012;142(4):469A. doi: 10.1378/chest.1390830.
- Li S, Liu J, Yuan Y, et al. Case report: a study on the de novo KMT2D variant of Kabuki syndrome with Goodpasture’s syndrome by whole exome sequencing. Front Pediatr. 2022;10:933693. doi: 10.3389/fped.2022.933693.
- Doi T, Ohga S, Ishimura M, et al. Long-term liposteroid therapy for idiopathic pulmonary hemosiderosis. Eur J Pediatr. 2013;172(11):1475–1481. doi: 10.1007/s00431-013-2065-9.
- Doi T, Ohga S, Ishimura M, et al. Erratum to: long-term liposteroid therapy for idiopathic pulmonary hemosiderosis. Eur J Pediatr. 2015;174(12):1701–1701. doi: 10.1007/s00431-015-2638-x.
- Tobai H, Yano J, Sato N, et al. Successful liposteroid therapy for a recurrent idiopathic pulmonary hemosiderosis with down syndrome. Case Rep Pediatr. 2020;2020:5292947.